[TRVI] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[TRVI] Trevi Therapeutics, Inc.
Announcement Date
06-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -7.21%
YoY- -72.02%
Quarter Report
TRVI's Result
TRVI's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -13,273 -7,711 -8,273 -7,253 -7,389 -7,370 -5,679 15.18%
Tax -31 -13 -7 2 -11 -5 -25 3.64%
NP -13,242 -7,698 -8,266 -7,255 -7,378 -7,365 -5,654 15.22%
Tax Rate - - - - - - - -
Total Cost 13,242 7,698 8,266 7,255 7,378 7,365 5,654 15.22%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.13 -0.08 -0.12 -0.34 -0.41 -0.41 -0.63 -23.10%
EPS Diluted -0.13 -0.08 -0.12 -0.34 -0.41 -0.41 -0.63 -23.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.